Literature DB >> 20818351

FIT: a valuable but underutilized screening test for colorectal cancer-it's time for a change.

James E Allison1.   

Abstract

Although fecal immunochemical tests (FITs) have been used for colorectal cancer (CRC) screening in several countries for years, this has not been the case in the United States. The reasons for this are multifactorial, but if the United States hopes to increase screening rates, the evidence is in regarding FIT's benefits and potential. A publication in this issue of the American Journal of Gastroenterology provides "gold standard" evidence of its superiority over the standard guaiac test and opens opportunities for investigators to discover the most effective uses of this test for population screening.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20818351     DOI： 10.1038/ajg.2010.181

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


  9 in total

1.  Test characteristics of faecal immunochemical tests (FIT) compared with optical colonoscopy.

Authors:  Barcey T Levy; Camden Bay; Yinghui Xu; Jeanette M Daly; George Bergus; Jeffrey Dunkelberg; Carol Moss
Journal:  J Med Screen       Date:  2014-06-23       Impact factor: 2.136

2.  Barriers to colorectal cancer screening among publicly insured urban women: no knowledge of tests and no clinician recommendation.

Authors:  Christina M Robinson; Andrea N Cassells; Mary Ann Greene; Michael L Beach; Jonathan N Tobin; Allen J Dietrich
Journal:  J Natl Med Assoc       Date:  2011-08       Impact factor: 1.798

3.  Effect of Ambient Temperature Variations on Positivity of Manual Fecal Immunochemical Tests.

Authors:  Jeanette M Daly; Camden P Bay; Yinghui Xu; Barcey T Levy
Journal:  J Prim Care Community Health       Date:  2015-05-28

4.  Barriers and Facilitators to Colorectal Cancer Screening Among Rural Women in Community Clinics by Heath Literacy.

Authors:  Terry C Davis; James Morris; Alfred Rademaker; Laurie Anne Ferguson; Connie L Arnold
Journal:  J Womens Health Issues Care       Date:  2017-10-25

5.  A pilot study for using fecal immunochemical testing to increase colorectal cancer screening in Appalachia, 2008-2009.

Authors:  Brenda C Kluhsman; Eugene J Lengerich; Linda Fleisher; Electra D Paskett; Suzanne M Miller-Halegoua; Andrew Balshem; Marcyann M Bencivenga; Angela M Spleen; Paulette Schreiber; Mark B Dignan
Journal:  Prev Chronic Dis       Date:  2012       Impact factor: 2.830

6.  Comparison of patient preferences for fecal immunochemical test or colonoscopy using the analytic hierarchy process.

Authors:  Yinghui Xu; Barcey T Levy; Jeanette M Daly; George R Bergus; Jeffrey C Dunkelberg
Journal:  BMC Health Serv Res       Date:  2015-04-23       Impact factor: 2.655

7.  Fecal immunochemical test for colorectal cancer from a prospective cohort with 513,283 individuals: Providing detailed number needed to scope (NNS) before colonoscopy.

Authors:  Chien Hua Chen; Chi Pang Wen; Min Kuang Tsai
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

8.  Performance of a quantitative fecal immunochemical test for detecting advanced colorectal neoplasia: a prospective cohort study.

Authors:  Elizabeth G Liles; Nancy Perrin; Ana G Rosales; David H Smith; Adrianne C Feldstein; David M Mosen; Theodore R Levin
Journal:  BMC Cancer       Date:  2018-05-02       Impact factor: 4.430

9.  A Plasma-Based Protein Marker Panel for Colorectal Cancer Detection Identified by Multiplex Targeted Mass Spectrometry.

Authors:  Jeffrey J Jones; Bruce E Wilcox; Ryan W Benz; Naveen Babbar; Genna Boragine; Ted Burrell; Ellen B Christie; Lisa J Croner; Phong Cun; Roslyn Dillon; Stefanie N Kairs; Athit Kao; Ryan Preston; Scott R Schreckengaust; Heather Skor; William F Smith; Jia You; W Daniel Hillis; David B Agus; John E Blume
Journal:  Clin Colorectal Cancer       Date:  2016-03-25       Impact factor: 4.481
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.